[HTML] plos.org

[HTML][HTML] Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized …

D Tornyos, A Komócsi, A Bálint, P Kupó… - Plos One, 2022 - journals.plos.org
Objective As stroke represents one of the leading causes of mortality and disability
worldwide, we aimed to determine the preventive effect of different antiplatelet therapies …
被引用次数：11 相关文章

Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized …

D Tornyos, A Komócsi, A Bálint, P Kupó… - PLoS …, 2022 - search.ebscohost.com
Objective: As stroke represents one of the leading causes of mortality and disability
worldwide, we aimed to determine the preventive effect of different antiplatelet therapies …

Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized …

D Tornyos, A Komócsi, A Bálint, P Kupó… - PLoS …, 2022 - ui.adsabs.harvard.edu
Objective As stroke represents one of the leading causes of mortality and disability
worldwide, we aimed to determine the preventive effect of different antiplatelet therapies …

Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized …

D Tornyos, A Komócsi, A Bálint, P Kupó… - PloS …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective As stroke represents one of the leading causes of mortality and disability
worldwide, we aimed to determine the preventive effect of different antiplatelet therapies …
[HTML] nih.gov

[HTML][HTML] Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized …

D Tornyos, A Komócsi, A Bálint, P Kupó… - PLoS ONE, 2022 - ncbi.nlm.nih.gov
Objective As stroke represents one of the leading causes of mortality and disability
worldwide, we aimed to determine the preventive effect of different antiplatelet therapies …

Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized …

D Tornyos, A Komócsi, A Bálint, P Kupó… - Plos one, 2022 - europepmc.org
Objective As stroke represents one of the leading causes of mortality and disability
worldwide, we aimed to determine the preventive effect of different antiplatelet therapies …